Keyphrases
AIDS/HIV
80%
Diagnostic Ultrasound
66%
High-resolution Ultrasound
66%
Ultrasound System
66%
New Therapies
66%
Maculopapular Eruption
66%
Paraneoplastic Dermatomyositis
66%
Pustular Psoriasis
66%
Indinavir
66%
Pityriasis Rosea
66%
Double Lip
66%
Unusual Presentation
66%
Lichen Planus pigmentosus
66%
Group A Streptococcal Infection
66%
Bacillary Angiomatosis
66%
Acanthamoeba
66%
Adrenocorticotropic Hormone Therapy
66%
Newborn Skin
66%
Xenobiotics
66%
Pigmentation
66%
Hydroxyurea Therapy
66%
Polycythemia Vera
66%
Transdermal
66%
Myopathic
66%
Reaction Pattern
66%
Skin Hyperpigmentation
66%
Lichen Myxedematosus
66%
Premature Infant
66%
Topical Retinoids
66%
Combination Therapy
66%
Dyspigmentation
66%
Chemical Peels
66%
Dermatologist
61%
Hyperpigmentation
57%
Cutaneous Disease
50%
Post-streptococcal
50%
Buccal mucosa
44%
Differential Diagnosis
44%
Hydroxyurea
44%
Pigmentary Changes
35%
Dyschromia
33%
3D Image
33%
Skin Diseases
33%
B-mode Image
33%
Diagnostic Purposes
33%
Non-invasive Assessment
33%
Neoplastic Processes
33%
Computer-assisted
33%
Medical Diagnostics
33%
Inflammatory Process
33%
Medicine and Dentistry
Dermatology
100%
Disease
100%
Dermatosis
94%
Dermatological Agent
83%
Hyperpigmentation
83%
Diagnosis
77%
Combination Therapy
66%
Human Immunodeficiency Virus
66%
Serositis
66%
Group A Streptococcal Infection
66%
Polycythemia vera
66%
Pigmentation
66%
Guttate Psoriasis
66%
Differential Diagnosis
66%
Pityriasis Rosea
66%
Retinoid
66%
Hydroxyurea
66%
Morphology
66%
Bacillary Angiomatosis
66%
Lip
66%
Lichen Planus
66%
Lichen Myxedematosus
66%
Neonatal Infant
66%
Hormone Therapy
66%
Acanthamoeba
66%
Xenobiotic Agent
66%
Transdermal
66%
Corticotropin
66%
Dermatomyositis
66%
Prematurity
66%
Sequela
50%
Drug Therapy
46%
Neck
33%
Buccal Mucosa
33%
Acanthamoeba Infection
33%
Clinical Finding
33%
Arm
33%
Urticaria
33%
Mucosa
33%
Eczema
33%
Psoriasis
33%
Oncogenesis and Malignant Transformation
33%
Streptococcus
33%
Mental Function
33%
Opportunistic Infection
33%
Sinusitis
33%
Paraneoplastic Syndrome
33%
Topical Agent
26%
Immunocompromised Patient
22%
Edema
22%